Colorectal cancer in 2014: Progress in defining first-line and maintenance therapies

Joleen M. Hubbard, Axel Grothey

Research output: Contribution to journalReview article

25 Scopus citations

Abstract

The results of several clinical trials in metastatic colorectal cancer presented in 2014 will influence clinical practice. These findings include definitive data from phase III trials comparing bevacizumab and cetuximab-based therapy in the first-line, studies elucidating the value of maintenance therapy after induction treatment, and data on new agents in this disease.

Original languageEnglish (US)
Pages (from-to)19-20
Number of pages2
JournalNature Reviews Gastroenterology and Hepatology
Volume12
Issue number1
DOIs
StatePublished - Jan 1 2015

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Fingerprint Dive into the research topics of 'Colorectal cancer in 2014: Progress in defining first-line and maintenance therapies'. Together they form a unique fingerprint.

  • Cite this